AGP Executive Report
Last update: 10 hours agoDEA Rescheduling Fight: DEA and anti-marijuana groups filed final briefs in the hearing over Trump’s proposal to move cannabis from Schedule I to Schedule III, with DEA arguing marijuana has accepted medical use and safety under medical supervision. Cannabis + Heart Health: A UCSF-led trial found habitual cannabis users had about 9% fewer premature heartbeats on days they inhaled cannabis versus days they abstained, adding nuance to cardiovascular risk talk. Georgia Medical Access: Georgia’s expanded medical marijuana program drove enrollment up fast, and officials say mail delivery could soon reach patients. Homegrow Surge (South Dakota): South Dakota reported a 1,072% jump in licensed home cultivators since 2022, prompting lawmakers to consider tighter regulation. Youth Trends (Vermont): Vermont’s latest survey shows improving teen mental health and lower reported marijuana, vaping, and alcohol use. Aviation Drug-Testing Push (India): Pilots’ union wants DGCA to overhaul drug-testing rules after an Air India incident, including higher random testing and oral-fluid screening. Public Health/Community: California begins phasing out paraquat after manufacturers withdrew health data, while a WA man died at a music festival after suspected drug poisoning.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
